Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

Bayer's Eylea wins approval in Europe to treat retinal vein occlusion German pharmaceutical firm Bayer HealthCare has received approval from the European Commission for Eylea (aflibercept solution for injection into the eye) to treat patients with visual impairment due to macular edema secondary to retinal vein occlusion (RVO). Drug Research > Drug Delivery > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

GSK's COPD treatment Encruse Ellipta gets Japanese approval
By PBR Staff Writer
GlaxoSmithKline (GSK) has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Encruse Ellipta (umeclidinium) for the relief of various symptoms due to airway obstruction with chronic obstructive pulmonary diseases (COPD).
News
Teikoku gets FDA acknowledgment of receipt for Docetaxel Injection
By PBR Staff Writer
Teikoku Pharma USA (TPU) has received an acknowledgment of the receipt from the US Food and Drug Administration (FDA) for a 505(b)(2) new drug application (NDA) for Docetaxel Injection Concentrate, Non-Alcohol Formula.
News

Drug Discovery & Development

Mast Therapeutics to develop vepoloxamer to treat chronic heart failure
By PBR Staff Writer
US-based biopharmaceutical firm Mast Therapeutics is planning to develop vepoloxamer (MST-188) to treat patients with chronic heart failure.
News
Lilly partners with China's Innovent for new oncology therapies
By PBR Staff Writer
Eli Lilly and Company and China-based biopharmaceutical firm Innovent Biologics have collaborated to create possible new treatment options for cancer patients in China and around the world.
News